News

INC Research announced a strategic collaboration with DrugDev to complete integration with and implementation of DrugDev’s SiteCloud platform.

Combined solution can help identify trial risks in operational and clinical data before traditional methods.

Certara®, a global biosimulation technology-enabled drug development consultancy, and CISCRP, an independent nonprofit organization dedicated to educating and informing the public and patients about clinical research, announced that they are partnering to produce high-quality lay summaries of clinical trials.

Accenture has expanded its Accenture Life Sciences Cloud for Research and Development (R&D) powered by Oracle with the addition of enhanced clinical data management capabilities.

Since its inception in early 2014, the SAG initiative has exercised considerable impact on the clinical research landscape by inciting important dialogue between site professionals and industry leaders related to current and evolving practices.

PPD has opened a central laboratory in Shanghai, China, to meet growing scientific and technical laboratory client demand for these services in China.

Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, announced that it has received a project grant as part of a consortium.

The shift from volume- to performance-based payment is propelling life sciences companies to seek concrete data and medical evidence – both to understand patient care and to demonstrate the effectiveness, safety and value of drug therapies.

INC Research announced the formation of a new Site Advocacy Group (SAG) under the auspices of its relationship with the Society for Clinical Research Sites (SCRS).

Quintiles announced a strategic alliance with Hospital Italiano of Buenos Aires as part of the company’s Prime Site program.

ERT announced the launch of the Insights Cloud™, a suite of data analytics, visualization, and workflow applications.

New faces among the Pharma Industry rise the ranks.

Figure 1: The Problem 

While some countries are more progressive in approaching this challenge by virtue of mandatory, free of charge, molecular testing on all patients, this varies greatly in other countries based on institutional policy and insurance reimbursement.

Clinipace Worldwide has announced the takeover of Accovion, a CRO with a head office in Frankfurt (Eschborn), Germany.

Accovion Strengthens Clinipace’s Operational and Therapeutic Expertise Within Europe